PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | C0020538|hypertension |
| Sentences | 247 |
| PubMedID- 22845816 | The association of hypertension with valvular heart disease and atrial fibrillation was a predictive variable of stroke recurrence but none of these variables was statistically significant when they were independently analyzed. |
| PubMedID- 25362943 | Objectives: eisenmenger syndrome (es) occurs as the most advanced form of pulmonary arterial hypertension (pah) in patients with congenital heart disease. |
| PubMedID- 20196994 | Pulmonary hypertension due to left heart disease is a pathophysiological and hemodynamic state which is present in a wide range of clinical conditions that affect left heart structures. |
| PubMedID- 21875514 | Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies. |
| PubMedID- 23592742 | Pulmonary hypertension (ph) due to left heart disease is classified as group ii according to the dana point classification, which includes left ventricular systolic and/or diastolic left heart failure, and left-sided valvular disease. |
| PubMedID- 25650280 | [pulmonary hypertension associated with congenital heart disease and eisenmenger syndrome]. |
| PubMedID- 24790070 | Objectives: to assess the relationship of c-reactive protein (crp) to clinical outcome and mortality in adults with pulmonary arterial hypertension (pah) associated with congenital heart disease (chd-pah). |
| PubMedID- 26571701 | Treatment for hypertension associated with cerebrovascular disease/heart disease]. |
| PubMedID- 26426649 | Multivariate adjustments were made for age, sex, preexisting hypertension, history of ischemic heart disease, blood glucose level upon arrival, estimated gfr, and prior use of alpha- or beta-blockers. |
| PubMedID- 20549685 | Pulmonary arterial hypertension associated with congenital heart disease (apah-chd) (n = 61, 34%) was more common than idiopathic pah (ipah) (n = 36, 20%). |
| PubMedID- 25549894 | Eisenmenger's syndrome (es) is the most advanced form of pulmonary arterial hypertension (pah) associated with congenital heart diseases (chd). |
| PubMedID- 25535690 | The aim of this study was to determine whether baseline characteristics and clinical events associate with mortality in patients with pulmonary hypertension (pah) due to congenital heart disease (chd). |
| PubMedID- 22086272 | Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era. |
| PubMedID- 22291986 | The occurrence of hypertension in combination with heart disease, diabetes, or stroke, respectively was more likely than expected, as well as the occurrence of eye diseases in combination with diabetes, joint diseases or lung diseases. |
| PubMedID- 24826287 | Heart transplantation in a 14-year-old boy in the presence of severe out-of-proportion pulmonary hypertension due to restrictive left heart disease: a case report. |
| PubMedID- 23056593 | Age, diabetes, hyperlipidemia, hypertension, hyperuricemia, use of nephrotoxic medications, coronary heart disease and history of ckd were independently associated with impaired renal function and urinary abnormalities. |
| PubMedID- 22748905 | Pulmonary hypertension associated with left-sided heart disease. |
| PubMedID- 21769595 | Perioperative management of pulmonary hypertension in children with critical heart disease. |
| PubMedID- 21371683 | Ambrisentan for pulmonary arterial hypertension due to congenital heart disease. |
| PubMedID- 25704592 | Right heart failure may develop from pulmonary arterial hypertension or various forms of congenital heart disease. |
| PubMedID- 22837863 | Indeed, in murine models of pulmonary hypertension associated with left heart disease and in monocrotaline-induced rodent pulmonary hypertension, treatment with a mast cell stabilizer or use of mast cell deficient rats attenuated vascular remodeling. |
| PubMedID- 24081196 | The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease. |
| PubMedID- 25847058 | Methods: using micrornas microarray, we profiled the micrornas in the lung specimen from 12 congenital heart disease patients, (6 with pulmonary arterial hypertension and the others without). |
| PubMedID- 24361805 | Background: pulmonary hypertension due to left heart disease is very common. |
| PubMedID- 24037633 | Pulmonary hypertension associated with left heart disease. |
| PubMedID- 22276217 | ¶adjusted for: age, socioeconomic status, hypertension, diabetes, family history of heart disease, indoor smoking and acute psycho-social stress. |
| PubMedID- 23129906 | Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease. |
| PubMedID- 20592995 | Advanced valvular heart disease with secondary pulmonary hypertension due to impaired diastolic and/or systolic function of the left ventricle may support the occurrence of csa. |
| PubMedID- 23032553 | Therefore, improving symptoms and avoiding adverse outcomes in patients with ph requires the following: (1) understanding the optimal use of echocardiography for the diagnosis of ph; (2) recognizing the utility and proper interpretation of invasive hemodynamic testing prior to starting pulmonary vasodilator therapy; (3) differentiating pah from pulmonary venous hypertension due to left heart disease; and (4) understanding the appropriate treatment strategies for ph and resultant right heart failure. |
| PubMedID- 26262457 | Summary: pulmonary hypertension in the context of left heart disease is the most common form of pulmonary hypertension encountered in clinical practice and is associated with worse prognosis in patients being considered for cardiac transplantation. |
| PubMedID- 23130100 | [19] this regression is not observed in patients with congenital heart disease associated with pulmonary hypertension, which may contribute to their relatively good outcome compared to patients with pah. |
| PubMedID- 24814894 | Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. |
| PubMedID- 23213519 | Pulmonary hypertension due to left heart disease (clinical group 2) is defined as postcapillary (pulmonary capillary wedge pressure ≥ 15 mmhg) while precapillary (pulmonary capillary wedge pressure ≤ 15 mmhg) pulmonary hypertension presents in other groups. |
| PubMedID- 25604592 | Pulmonary arterial hypertension associated with congenital heart disease and eisenmenger syndrome: current practice in pediatrics. |
| PubMedID- 23351920 | However, its long-term efficacy and safety in patients with pulmonary arterial hypertension (pah) associated with complex congenital heart disease (chd) is unknown. |
| PubMedID- 20814475 | The introduction of inhaled nitric oxide (ino) has added a new dimension to the treatment of pulmonary hypertension associated with congenital heart disease. |
| PubMedID- 20143207 | Pulmonary arterial hypertension associated with congenital heart disease constitutes a heterogenous group of conditions and has been characterized by congenital systemic-to-pulmonary shunts. |
| PubMedID- 24575133 | Constructing a score which indicates how well an individual follows a diet similar to the dash plan could be helpful in assessing the relationship between a dash-style diet and chd.11 a study showed that risk of chd decreased in women, the dietary pattern of whom was similar to dash pattern.12 in addition, another study reported that greater concordance with dash diet guidelines was associated with a somewhat lower incidence of hypertension and mortality due to coronary heart diseases, stroke, or total cardiovascular diseases. |
| PubMedID- 20637015 | Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease. |
| PubMedID- 21093377 | A review of the management of pulmonary arterial hypertension associated with congenital heart disease. |
| PubMedID- 26471823 | There are several mechanisms of pulmonary hypertension in patients with adult congenital heart disease, and understanding them requires a systematic approach to define the patient's hemodynamics and physiology. |
| PubMedID- 23720182 | [pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation]. |
| PubMedID- 23404824 | Individuals reporting uncontrolled hypertension, a history of coronary heart disease, stroke, peripheral arterial disease, hepatitis b or c, cirrhosis, hiv, type 2 diabetes requiring medical therapy that increases the risk of hypoglycemia, cancer within the last 5 years, or significant psychiatric illness were excluded. |
| PubMedID- 26459910 | We validated our methods by quantifying mirna expression profiles in the sera of the patients with pulmonary arterial hypertension associated with congenital heart disease. |
| PubMedID- 21893489 | Pulmonary arterial hypertension associated with congenital heart disease (pah-chd) using three different response criteria. |
| PubMedID- 22257586 | However, it is particularly useful in patient with pulmonary arterial hypertension associated with congenital heart disease. |
| PubMedID- 25076997 | Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary hypertension due to left heart disease. |
| PubMedID- 24039255 | Despite the importance of pulmonary veins in normal lung physiology and the pathobiology of pulmonary hypertension with left heart disease (ph-lhd), pulmonary veins remain largely understudied. |
| PubMedID- 22313804 | Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease. |
| PubMedID- 25701970 | Conclusion: the results of this pilot study suggest that endothelin receptor antagonism improves the functional status of patients with tte evidence of pulmonary hypertension due to valvular heart disease. |